Abstract:The α-D-glucopyranoside and its derivatives were as the cardinal investigation for developing an effective medication to treat the highest deadly white spot syndrome virus (WSSV) diseases in Shrimp. In our forthcoming work, both computational tools, such as molecular docking, quantum calculations, pharmaceutical kinetics, ADMET, and their molecular dynamics, as well as the experimental trial against WSSV, were executed to develop novel inhibitors. In the beginning, molecular docking was carried out to determine inhibitors of the four targeted proteins of WSSV (PDB ID: 2ED6, 2GJ2, 2GJI, and 2EDM), and to determine the binding energies and interactions of ligands and proteins after docking. The range of binding affinity was found to be between -5.40 and -7.00 kcal/mol for the protein 2DEM, from -5.10 to 6.90 kcal/mol for the protein 2GJ2, from -4.70 to -6.2 kcal/mol against 2GJI, and from -5.5 kcal/mol to -6.6 kcal/mol for the evolved protein 2ED6 whereas the L01 and L03 display the highest binding energy in the protein 2EDM. After that, the top-ranked compounds (L01, L02, L03, L04, and L05), based on their high binding energies, were tested for molecular dynamics (MD) simulations of 100 ns to verify the docking validation and stability of the docked complex by calculating the root mean square deviation (RMSD) and root mean square fluctuation (RMSF). The molecules with the highest binding energy were then picked and compared to the standard drugs that were been applied to fish experimentally to evaluate the treatment at various doses. Consequently, approximately 40-45% cure rate was obtained by applying the dose of oxytetracycline (OTC) 50% with vitamin C with the 10.0 g/kg feed for 10 days. These drugs (L09 to L12) have also been executed for molecular docking to compare with α-D-glucopyranoside and its derivatives (L01 to L08). Next, the evaluation of pharmacokinetic parameters, such as drug-likeness and Lipinski's principles; absorption; distribution; metabolism; excretion; and toxicity (ADMET) factors, were employed gradually to further evaluate their suitability as inhibitors. It was discovered that all ligands (L01 to L12) were devoid of hepatotoxicity, and the AMES toxicity excluded L05. Additionally, all of the compounds convey a significant aqueous solubility and cannot permeate the blood-brain barrier. Moreover, quantum calculations based on density functional theory (DFT) provide the most solid evidence and testimony regarding their chemical stability, chemical reactivity, biological relevance, reactive nature and specific part of reactivity. The computational and virtual screenings for in silico study reveals that these chosen compounds (L01 to L08) have conducted the inhibitory effect to convey as a possible medication against the WSSV than existing drugs (L09, L10, L11 and L12) in the market. Next the drugs (L09, L10, L11 and L12) have been used in trials.

In-vitro studies on antiviral effects of Galaxaura elongata marine algae on white spot syndrome virus

Investigation of the New Inhibitors by Sulfadiazine and Modified Derivatives of α-D-glucopyranoside for White Spot Syndrome Virus Disease of Shrimp by In Silico: Quantum Calculations, Molecular Docking, ADMET and Molecular Dynamics Study

Evaluation of the Antiviral Activity of Chlorogenic Acid Against White Spot Syndrome Virus

A novel antiviral coumarin derivative as a potential agent against WSSV infection in shrimp seedling culture

Antiviral effects of Sarcodia suae water extracts against vesicular stomatitis virus infection

The influence of temperature and β-1,3-glucans on the occurrence of white spot syndrome virus and white spot disease in post-larvae of Penaeus vannamei shrimp

Gardenia Jasminoides Ellis Inhibit White Spot Syndrome Virus Replication in Red Swamp Crayfish Procambarus Clarkii

Antiviral Activity of Geniposidic Acid Against White Spot Syndrome Virus Replication in Red Swamp Crayfish Procambarus Clarkii

Infection of WSSV shows potential promise of a novel antiviral amino-nitrophenyl medicine for application in culture of shrimp seedling

Dietary Chitosan Nanoparticles Protect Crayfish Procambarus Clarkii Against White Spot Syndrome Virus (wssv) Infection

The protection of CpG ODNs and Yarrowia lipolytica harboring VP28 for shrimp Litopenaeus vannamei against White spot syndrome virus infection

Potential Application of a Small Molecule Compound in Aquaculture Against WSSV Infection by Maintaining the Homeostasis of Intestinal Microbiota

Difference in medication pattern potentially enhances antiviral efficiency of a novel amino-fluorophenyl compound on WSS risk in shrimp seedling culture

Role of Anti-Lipopolysaccharide Factor from the Black Tiger Shrimp, Penaeus Monodon, in Protection from White Spot Syndrome Virus Infection

Antiviral activity of esculin against white spot syndrome virus: A new starting point for prevention and control of white spot disease outbreaks in shrimp seedling culture

Study on Anti-infectivity to White Spot Syndrome Virus of Penaeus vanamei by Oral Peptidoglycan Preparation

Effects of Β-Glucan Derivatives on the Immunity of White Shrimp Litopenaeus Vannamei and Its Resistance Against White Spot Syndrome Virus Infection

Antiviral effect of red microalgal polysaccharides on Herpes simplex and Varicella zoster viruses

Evaluation on the Antiviral Activity of Genipin Against White Spot Syndrome Virus in Crayfish

Evaluation of a new Argovit as an antiviral agent included in feed to protect the shrimp Litopenaeus vannamei against White Spot Syndrome Virus infection

A review on molecular detection techniques of white spot syndrome virus: Perspectives of problems and solutions in shrimp farming